10203.html
BridgeBio Oncology and Helix enter definitive merger agreement
Mon, 03 Mar 2025 04:16:39 GMT
The PIPE, featuring several investors, funds the advancement of BBOT's three drug development programmes: BBO-8520, BBO-10203 and BBO-11818. The merger is expected to provide BBOT with $550m in cash.